Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in LQDA — Liquidia Corp

CIK 1423053 MIAMI, FL
Back to LQDA Full portfolio

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,699,268
-$21,899,491 QoQ
Shares Held
151,014
-81.1% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Derivatives in LQDA

reported options exposure · as of Mar 31, 2026
CallValue
$56,357,142
CallShares
1,493,300
PutValue
$10,216,218
PutShares
270,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $927,090,430 across 59 Drug Manufacturers - Specialty & Generic names. LQDA ranks #23 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 360,643 $213,854,086
2 INDV
Indivior Pharmaceuticals, Inc.
 3,574,044 $108,936,860
3 ELAN
Elanco Animal Health Inc
 4,387,127 $104,983,948
4 ALKS
Alkermes plc.
 2,241,584 $79,262,409
5 SUPN
Supernus Pharmaceuticals, Inc.
 1,493,446 $77,196,223
6 ZTS
Zoetis Inc.
 501,011 $59,224,510
7 VTRS
Viatris Inc
 3,993,155 $53,947,523
8 KNSA
Kiniksa Pharmaceuticals International, plc
 474,750 $22,859,212

All Filings in LQDA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,216,218 270,700
2026-03-31 $5,699,268 151,014
2026-03-31 $56,357,142 1,493,300
2025-12-31 $2,397,055 69,500
2025-12-31 $27,598,759 800,196
2025-12-31 $25,374,293 735,700
2025-09-30 $10,223,085 449,564
2025-09-30 $17,825,886 783,900
2025-09-30 $2,376,330 104,500
2025-06-30 $2,438,422 195,700
2025-06-30 $4,622,049 370,951
2025-06-30 $2,489,508 199,800
2025-03-31 $7,471,730 506,558
2025-03-31 $1,128,375 76,500
2025-03-31 $1,305,375 88,500
2024-12-31 $4,616,552 392,564
2024-12-31 $1,017,240 86,500
2024-12-31 $2,767,128 235,300
2024-09-30 $984,000 98,400
2024-09-30 $1,474,440 147,444
2024-09-30 $2,174,000 217,400
2024-06-30 $1,954,800 162,900
2024-06-30 $430,800 35,900
2024-03-31 $2,964,750 201,000
2024-03-31 $88,647 6,010
2024-03-31 $1,128,375 76,500
2023-12-31 $725,409 60,300
2023-12-31 $2,480,586 206,200
2023-12-31 $349,279 29,034
2023-09-30 $620,052 97,800
2023-09-30 $237,750 37,500
2023-09-30 $406,394 64,100
2023-06-30 $203,315 25,900
2023-06-30 $713,565 90,900
2023-06-30 $377,710 48,116
2023-03-31 $9,604 1,390
2023-03-31 $679,944 98,400
2023-03-31 $269,490 39,000
2022-12-31 $1,450,449 227,700
2022-12-31 $315,315 49,500
2022-09-30 $750,458 137,952
2022-09-30 $2,232,576 410,400
2022-09-30 $458,592 84,300
2022-06-30 $1,947,497 446,674
2022-06-30 $180,940 41,500
2022-06-30 $111,616 25,600
2022-03-31 $5,624,825 783,402
2022-03-31 $272,840 38,000
2021-12-31 $279,980 57,491
2021-12-31 $149,022 30,600

Report a Problem

Category
Description
Email (optional, for follow-up)